Literature DB >> 17598040

Vulvar vestibulitis and risk factors: a population-based case-control study in Oslo.

Karin Edgardh1, Michael Abdelnoor.   

Abstract

Vulvar vestibulitis is a major cause of entry dyspareunia in young women. The aim of this study was to evaluate a self-reported history of bacterial vaginosis, candidiasis, use of oral contraception and nulli-pregnancy as risk factors for vestibulitis. A retrospective examination of medical records was performed for 45 patients with vestibulitis from a vulvar clinic in Oslo, median age 24 years, age range 19-49 years. Four controls per case were selected randomly from the same Oslo source population as the cases. Age-matching was not performed, as matching does not control for confounding in the case-control design. Controls anonymously answered a postal questionnaire, response rate 61%. The crude effect for the major potential predictors for vulvar vestibulitis was estimated, and stratification on age for the major potential predictors. The method of Mantel Haenszel was used to quantify confounders, and control for multi-confounders and the gradient effect of different covariates was performed. The major confounder was age. Independent risk factors for vestibulitis were nulli-pregnancy, odds ratio (OR) 8.4 (95% confidence interval (CI) 2.8-25.2) and bacterial vaginosis, OR 3.37 (95% CI 1.06-10.6). Adjusting for age diluted the effect of oral contraception and frequent treatment for candidiasis. This study is the third case-control study identifying bacterial vaginosis as a risk factor for vestibulitis. Thus, it remains to be investigated whether abnormal vulvo-vaginal microbiota belongs to the aetiology of vulvar vestibulitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17598040     DOI: 10.2340/00015555-0250

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  5 in total

Review 1.  Hormonal contraception and pelvic floor function: a systematic review.

Authors:  Rita Champaneria; Ruben Mamprin D'Andrea; Pallavi M Latthe
Journal:  Int Urogynecol J       Date:  2015-09-25       Impact factor: 2.894

2.  The treatment of vestibulodynia with topical estradiol and testosterone.

Authors:  Lara J Burrows; Andrew T Goldstein
Journal:  Sex Med       Date:  2013-08       Impact factor: 2.491

3.  Evaluation of Gut Microbiota in Patients With Vulvovestibular Syndrome.

Authors:  Laura Coda; Paola Cassis; Stefania Angioletti; Cristina Angeloni; Stefania Piloni; Cristian Testa
Journal:  J Clin Med Res       Date:  2021-02-25

4.  The Vaginal Microbiome: III. The Vaginal Microbiome in Various Urogenital Disorders.

Authors:  Francesco De Seta; Risa Lonnee-Hoffmann; Giuseppina Campisciano; Manola Comar; Hans Verstraelen; Pedro Vieira-Baptista; Gary Ventolini; Ahinoam Lev-Sagie
Journal:  J Low Genit Tract Dis       Date:  2022-01-01       Impact factor: 1.925

Review 5.  Similarities between interstitial cystitis/bladder pain syndrome and vulvodynia: implications for patient management.

Authors:  Jennifer Yonaitis Fariello; Robert M Moldwin
Journal:  Transl Androl Urol       Date:  2015-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.